Congressional Research Service Reports - Browse

ABOUT BROWSE FEED
The Public Health and Medical Response to Disasters: Federal Authority and Funding
This report examines (1) the authorities and coordinating mechanisms of the President and the Secretary of Health and Human Services (HHS) in providing routine assistance, and assistance pursuant to emergency or major disaster declarations and/or public health emergency determinations; (2) mechanisms to assure a coordinated federal response to public health and medical emergencies, and overlaps or gaps in agency responsibilities; and (3) existing mechanisms, potential gaps, and proposals for financing the costs of a response to public health and medical emergencies.
The Public Health and Medical Response to Disasters: Federal Authority and Funding
This report examines (1) the authorities and coordinating mechanisms of the President and the Secretary of HHS in providing routine assistance, and assistance pursuant to emergency or major disaster declarations and/or public health emergency determinations; (2) mechanisms to assure a coordinated federal response to public health and medical emergencies, and overlaps or gaps in agency responsibilities; and (3) existing mechanisms, potential gaps, and proposals for financing the costs of a response to public health and medical emergencies.
The Public Health and Medical Response to Disasters: Federal Authority and Funding
No Description Available.
The Public Health and Medical Response to Disasters: Federal Authority and Funding
No Description Available.
Regulation of Clinical Tests: In Vitro Diagnostic (IVD) Devices, Laboratory Developed Tests (LDTs), and Genetic Tests
In vitro diagnostic (IVD) devices are used in the analysis of human samples, such as blood or tissue, to provide information in making health care decisions. Examples of IVDs include pregnancy test kits or blood glucose tests for home use; laboratory tests for infectious disease, such as HIV or hepatitis, and routine blood tests, such as cholesterol and anemia; and tests for various genetic diseases or conditions. More recently, a specific type of diagnostic test--called a companion diagnostic--has been developed that may be used to select the best therapy, at the right dose, at the correct time for a particular patient; this is often referred to as personalized or precision medicine. This report provides an overview of federal regulation of IVDs by FDA, through the Federal Food, Drug, and Cosmetics Act (FFDCA) and the Public Health Service Act (PHSA), and by CMS, through the Clinical Laboratory Improvement Amendments (CLIA) of 1988.
Regulation of Clinical Tests: In Vitro Diagnostic (IVD) Devices, Laboratory Developed Tests (LDTs), and Genetic Tests
In vitro diagnostic (IVD) devices are used in the analysis of human samples, such as blood or tissue, to provide information in making health care decisions. Examples of IVDs include pregnancy test kits or blood glucose tests for home use; laboratory tests for infectious disease, such as HIV or hepatitis, and routine blood tests, such as cholesterol and anemia; and tests for various genetic diseases or conditions. More recently, a specific type of diagnostic test--called a companion diagnostic--has been developed that may be used to select the best therapy, at the right dose, at the correct time for a particular patient; this is often referred to as personalized or precision medicine. This report provides an overview of federal regulation of IVDs by FDA, through the Federal Food, Drug, and Cosmetics Act (FFDCA) and the Public Health Service Act (PHSA), and by CMS, through the Clinical Laboratory Improvement Amendments (CLIA) of 1988.
Regulation of Plant-Based Pharmaceuticals
No Description Available.
The Role of the Department of Defense During A Flu Pandemic
This report focuses on the role of the Department of Defense (DOD) in supporting the nation's domestic response effort to a flu pandemic, although it will also touch on DOD's international role.
The Ryan White HIV/AIDS Program: Overview and Impact of the Affordable Care Act
This report discusses the impact of the Affordable Care Act on the Ryan White HIV/AIDS Program, which makes federal funds available to metropolitan areas and states to that provide a number of health care services for HIV/AIDS patients.
Safe at Home? Letting Ebola-Stricken Americans Return
This report examines the U.S. practice of isolation and quarantine for citizens arriving in the country who have been infected with or exposed to a dangerous communicable disease. The report frames this information in the context of the two American healthcare workers who were brought back into the U.S. for treatment after contracting the Ebola virus in West Africa in the Summer of 2014.
Safe Harbor for Preclinical Use of Patented Inventions in Drug Research and Development:
No Description Available.
The Safety of Air Ambulances
No Description Available.
The Safety of Air Ambulances
No Description Available.
The Schiavo Case: Legal Issues
No Description Available.
Science, Technology, and Medicine: Issues Facing the 105th Congress, First Session
No Description Available.
Science, Technology, and Medicine: Issues Facing the 105th Congress, Second Session
No Description Available.
Science, Technology, and Medicine: Issues Facing the 106th Congress, First Session
No Description Available.
Science, Technology, and Medicine: Issues Facing the 106th Congress, Second Session
No Description Available.
Selected Health Funding in the American Recovery and Reinvestment Act of 2009
The American Recovery and Reinvestment Act (ARRA) of 2009, which the President signed into law on February 17, 2009, provided more than $17 billion in supplemental FY2009 discretionary appropriations for biomedical research, public health, and other health-related programs within the Department of Health and Human Services (HHS). This report discusses the health-related programs and activities funded by ARRA, including details of how the administering HHS agencies and offices plan to allocate, award, and spend the funds.
Selected Health Funding in the American Recovery and Reinvestment Act of 2009
This report compares funding provided for selected Health and Human Services (HHS) programs in the American Recovery and Reinvestment Act (ARRA) conference report (H.Rept. 111-16) with the recommendations in the House- and Senate-passed versions of H.R. 1. It also briefly discusses ARRA's provisions on HIT and comparative effectiveness research as they relate to the funding.
Severe Acute Respiratory Syndrome (SARS): Public Health Situation and U.S. Response
No Description Available.
A Shortage of Registered Nurses: Is It on the Horizon or Already Here?
The largest, traditionally female-dominated health care occupation is registered nurses (RNs). It has been asserted that there are too few RNs available today to meet employers’ needs, that is, there is a shortage of nurses at the present time. It also has been estimated that there could well be a shortage of RNs in the not-too-distant future. This report will analyze the labor market conditions facing RNs and their employers.
A Shortage of Registered Nurses: Is It on the Horizon or Already Here?
The largest traditionally female-dominated health care occupation is registered nurses (RNs). It has been asserted that there is an ongoing nationwide shortage of RNs of various kinds and in various sectors of the health care services industry. Before the latest (mid-2002) release of supply-demand projections from the U.S. Health Resources and Services Administration (HRSA), it was estimated, based in whole or part on 1996 HRSA projections, that there would likely be a shortage of RNs in 2007 or shortly thereafter. This report first will analyze recent trends in the RN labor market and then examine HRSA’s new projections, which moved up the date of an RN shortage to 2000.
Smallpox Vaccine Injury Compensation
This report discusses the Public Safety Officers’ Benefits Program, which provides for compensation of individuals injured by vaccinations given as part of a countermeasure plan declared by the Secretary of Health and Human Services in preparation for potential hostile activities involving the smallpox virus.
Smallpox Vaccine Stockpile and Vaccination Policy
No Description Available.
Smokeless Tobacco: Snuff and Chewing Tobacco; Bibliography-in-Brief, 1983-1987
No Description Available.
Smokeless Tobacco: Snuff and Chewing Tobacco; Bibliography-in-Brief, 1983-1987
No Description Available.
Standardized Choices: Medigap Lessons for Medicare Part D
No Description Available.
State Laws on Human Cloning
No Description Available.
Stem Cell Research
This report provides background on the research and potential applications of research that uses embryonic and adult stem cells. It also provides information about the current federal and state regulatory landscape, related Congressional and international actions, and relevant ethical concerns.
Stem Cell Research
This report provides background on the research and potential applications of research that uses embryonic and adult stem cells. It also provides information about the current federal and state regulatory landscape, related Congressional and international actions, and relevant ethical concerns.
Stem Cell Research
No Description Available.
Stem Cell Research
No Description Available.
Stem Cell Research
No Description Available.
Stem Cell Research
No Description Available.
Stem Cell Research
No Description Available.
Stem Cell Research
No Description Available.
Stem Cell Research
No Description Available.
Stem Cell Research
No Description Available.
Stem Cell Research
No Description Available.
Stem Cell Research
No Description Available.
Stem Cell Research
No Description Available.
Stem Cell Research
No Description Available.
Stem Cell Research
No Description Available.
Stem Cell Research
No Description Available.
Stem Cell Research: Ethical Issues
This report discusses the ethical arguments that surround human embryonic stem cell research (ESR). Human stem cell research is controversial not because of its goals, but rather because of the means of obtaining some of the cells.
Substantive Due Process and a Right to Clone
No Description Available.
Suicide Prevention Efforts of the Veterans Health Administration
This report discusses seven areas of Veterans Health Administration (VHA) suicide prevention interventions: easy access to care, education, screening and treatment, limited access to lethal means, suicide hotline, media restrictions, and suicide prevention coordinators.
Suicide Prevention Efforts of the Veterans Health Administration
Responsibility for prevention of veteran suicide lies primarily with the Veterans Health Administration (VHA), within the Department of Veterans Affairs (VA). The VHA Strategic Plan for Suicide Prevention is based on a public health framework, which has three major components: (1) surveillance, (2) risk and protective factors, and (3) prevention interventions. This report identifies challenges the VHA faces in each component of suicide prevention and discusses potential issues for Congress.
Suicide, PTSD, and Substance Use Among OEF/OIF Veterans Using VA Health Care: Facts and Figures
This brief report addresses three relevant topics that affect veterans: suicide, posttraumatic stress disorder (PTSD), and substance use disorders.